FDA Rejects Vanda Pharma's Application for Gastroparesis Drug Tradipitant
Vanda said it will continue to pursue approval of tradipitant in gastroparesis, a condition that affects the stomach muscles and prevents proper stomach emptying, and that it plans to file a separate application later this year seeking a green light for the drug for the prevention of vomiting in motion sickness.
The FDA is citing the presence of a government-regulated ingredient due to its possible hazards for children and adults. The ...
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
2d
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
Verywell Health on MSN1h
Is Silicon Dioxide in Food Safe? A Dietitian ExplainsSilicon dioxide in food is generally regarded as safe. However, other forms and uses of silicon dioxide may pose health risks ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback